Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Arch Chemicals, Inc. (“Arch” or the “Company”) (NYSE: ARJ) relating to the proposed acquisition by Lonza Group Ltd., Inc. (“Lonza”).

Under the terms of the offer, Arch shareholders would receive $47.20 in cash for each share of Arch common stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Arch for not acting in Arch shareholders' best interests in connection with the sale process to Lonza. The transaction appears to be unfair, in part, given Arch’s recent positive results. Arch reported first quarter results that exceed analyst expectations. On May 3, 2011, Arch reported $325.5 million in revenue for the quarter. This represented a 9% increase over the same quarter in the previous year.

If you own shares of Arch and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, visiting http://brodsky-smith.com/313-arj-arch-chemicals-inc.html, or by calling toll free 877-LEGAL-90.

Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Arch Chemicals
Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Arch Chemicals